Last reviewed · How we verify

NCT07376590

Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial Aneurysms

Recruiting now Last updated 29 January 2026
What this trial tests

trial testing No intervention measures in Aneurysms in 164 participants. Currently enrolling.

Timeline
15 January 2026
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorFirst Affiliated Hospital of Zhejiang University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment164
Start date15 January 2026
Primary completion31 December 2027
Estimated completion31 December 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

First Affiliated Hospital of Zhejiang University

Who can join

Adults 18 to 80, any sex, with Aneurysms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using data obtained from the treatment of intracranial distal intracranial aneurysms with flow diverter, evaluate the effecy and safety of blood flow diverter for the endovascular treatment of distal intracranial aneurysms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention measures

Trials testing the same drug.

Other First Affiliated Hospital of Zhejiang University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07376590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing